What is BioArctic AB (publ)?
BioArctic AB (publ) develops biological drugs for patients with central nervous system disorders in Sweden.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
BioArctic AB (publ) develops biological drugs for patients with central nervous system disorders in Sweden. It engages in the research and development of innovative biological drugs, such as antibodies that address high unmet medical needs. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 2.93B, and a P/E ratio of 26.4x.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.